Goran Pharma Private Ltd – FDA 483, Nov 15, 2017
An FDA inspection of Goran Pharma Pvt Ltd in Sihor, India, revealed numerous significant deficiencies in their drug manufacturing operations. The firm lacked adequate microbiology laboratory facilities, failed to ensure proper personnel gowning, and did not consistently follow or establish written procedures for quality control, annual product reviews, and cGMP training. Critical issues were also identified in equipment maintenance, labeling control, water system integrity, supplier qualification, product release testing, and the overall stability study program for their drug products.
ID · db4984d7-0722-4b5d-818c-ff968df6d211
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.